High rate of adverse drug reactions with a novel tuberculosis re-treatment regimen combining triple doses of both isoniazid and rifampicin-Reference-Cited by-同舟云学术

High rate of adverse drug reactions with a novel tuberculosis re-treatment regimen combining triple doses of both isoniazid and rifampicin

Published:2023-08 Issue: Volume:133 Page:78-81
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Souleymane Mahamadou Bassirou^ORCID,Kadri Sani,Piubello Alberto^ORCID,Tsoumanis Achilleas,Soumana Alphazazi,Issa Hamidou,Amoussa Abdoulaziz Kabirou,Van Deun Armand^ORCID,Lynen Lutgarde,de Jong Bouke Catherine^ORCID,Decroo Tom

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference13 articles.

1. World Health Organization. Global tuberculosis report 2022. Geneva: World Health Organization, 2022.

2. Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding;Caminero;Int J Tuberc Lung Dis,2010

3. A systematic review of clinical outcomes on the WHO Category II retreatment regimen for tuberculosis;Cohen;Int J Tuberc Lung Dis,2018

4. Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis;Fregonese;Lancet Respir Med,2018

5. Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study;Makhado;Lancet Infect Dis,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment and Toxicity Considerations in Tuberculosis: A Narrative Review;Cureus;2024-06-19

2. High-dose, short-duration versus standard rifampicin for tuberculosis preventive treatment: a partially blinded, three-arm, non-inferiority, randomised, controlled trial;The Lancet Respiratory Medicine;2024-06

3. Isoniazid derivatization strategy of carboxyl-containing metabolites for LC-MS/MS-based targeted metabolomics;Analytical and Bioanalytical Chemistry;2023-08-25